B
Braidwell Portfolio holdings
AUM
$2.92B
1-Year Return
4.59%
This Quarter Return
-7%
1 Year Return
-4.59%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2.84B
AUM Growth
-$528M
(-16%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-41.6%
Top 10 Holdings %
Top 10 Hldgs %
40.1%
Holding
86
New
10
Increased
17
Reduced
14
Closed
17
Top Buys
| 1 |
Danaher
DHR
|
$63.4M |
| 2 |
argenx
ARGX
|
$47.4M |
| 3 |
Nuvalent
NUVL
|
$42.5M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$38.9M |
| 5 |
Krystal Biotech
KRYS
|
$36.1M |
Top Sells
| 1 |
Guardant Health
GH
|
$64.8M |
| 2 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$43.2M |
| 3 |
FNA
Paragon 28, Inc.
FNA
|
$39.6M |
| 4 |
BioNTech
BNTX
|
$35.3M |
| 5 |
Kiniksa Pharmaceuticals
KNSA
|
$33.1M |
Sector Composition
| 1 | Healthcare | 67.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Skye Bioscience
SKYE
$116M
| $1.31M | 0.05% |
825,732
| – | – |
|
52
Trevi Therapeutics
TRVI
$880M
| $453K | 0.02% |
+72,083
| New | +$453K |
|
|
AVDL
53
Avadel Pharmaceuticals
AVDL
$1.46B
| – | – |
-4,105,726
| Closed | -$43.2M |
|
|
54
BioNTech
BNTX
$24.9B
| – | – |
-309,865
| Closed | -$35.3M |
|
55
Bruker
BRKR
$4.52B
| – | – |
-353,200
| Closed | -$20.7M |
|
56
Candel Therapeutics
CADL
$268M
| – | – |
-1,600,000
| Closed | -$13.9M |
|
57
Exact Sciences
EXAS
$9.73B
| – | – |
-353,000
| Closed | -$19.8M |
|
58
4D Molecular Therapeutics
FDMT
$309M
| – | – |
-1,225,448
| Closed | -$6.83M |
|
59
Geron
GERN
$880M
| – | – |
-7,006,315
| Closed | -$24.8M |
|
60
Immatics
IMTX
$695M
| – | – |
-3,503,965
| Closed | -$24.9M |
|
61
Jasper Therapeutics
JSPR
$43.7M
| – | – |
-714,658
| Closed | -$15.3M |
|
62
Keros Therapeutics
KROS
$632M
| – | – |
-1,894,439
| Closed | -$30M |
|
63
Vaxcyte
PCVX
$4.17B
| – | – |
-222,424
| Closed | -$18.2M |
|
64
Protagonist Therapeutics
PTGX
$3.71B
| – | – |
-20,109
| Closed | -$776K |
|
65
Arcus Biosciences
RCUS
$1.23B
| – | – |
-802,100
| Closed | -$11.9M |
|
66
Viridian Therapeutics
VRDN
$1.52B
| – | – |
-34,094
| Closed | -$654K |
|
|
CBLL
67
CeriBell, Inc. Common Stock
CBLL
$452M
| – | – |
-210,000
| Closed | -$5.43M |
|
|
FNA
68
DELISTED
Paragon 28, Inc.
FNA
| – | – |
-3,834,809
| Closed | -$39.6M |
|
|
NVRO
69
DELISTED
NEVRO CORP.
NVRO
| – | – |
-1,698,768
| Closed | -$6.32M |
|